Join the Hot Flashes group to help and get support from people like you.
Hot Flashes News (Page 4)
Related terms: Hot Flushes
Could Tough Workouts Trigger a Hot Flash?
FRIDAY, May 31, 2024 – While going through menopause, many women who gain weight head to the gym for intense workouts, but new research suggests that too much exercise may help trigger another side...
More Physical Activity Tied to Higher Odds of Hot Flashes
FRIDAY, May 31, 2024 – Increases in physical activity increase the odds of menopause-related hot flashes, according to a study published online May 28 in Menopause. Sarah Witkowski, Ph.D., from ...
Fezolinetant Safe, Effective for Moderate-to-Severe Menopause Hot Flashes
MONDAY, May 20, 2024 – Fezolinetant is safe and effective for moderate-to-severe vasomotor symptoms (VMS), according to a study presented at the annual European Congress of Endocrinology, hosted by...
Long-Term Study of Postmenopausal Women Does Not Support Many Preventive Therapies
THURSDAY, May 2, 2024 – The longitudinal Women's Health Initiative trials do not support hormone therapy for cardiovascular disease prevention, calcium and vitamin D supplementation for universal...
Years Prior to Menopause Are Danger Zone for Depression
WEDNESDAY, May 1, 2024 – Women approaching menopause appear to be at higher risk of depression, a new review indicates. Women in the transition period prior to menopause are 40% more likely to...
Major Women's Health Study Supports Hormone Replacement Therapy in Early Menopause
WEDNESDAY, May 1, 2024 – Hormone replacement therapy can safely ease middle-aged women’s symptoms during early menopause, data from a major women’s health study show. Women younger than 60 can use ho...
FDA Approves Veozah (fezolinetant) for the Treatment of Vasomotor Symptoms Due to Menopause
TOKYO, May 13 2023 – Astellas Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Veozah (fezolinetant) 45 mg once daily for the treatment of moderate to severe v...
FDA Approves Brisdelle - First Non-Hormonal Treatment for Hot Flashes Associated with Menopause
June 28, 2013 --The U.S. Food and Drug Administration today approved Brisdelle (paroxetine) to treat moderate to severe hot flashes (vasomotor symptoms) associated with menopause. Brisdelle, which...
Further information
Related condition support groups
Related drug support groups
gabapentin, citalopram, mirtazapine, fluoxetine, venlafaxine, duloxetine, paroxetine, desvenlafaxine